OpenArc Corporate Advisory »

Monte Rosa Therapeutics shares owned by OpenArc Corporate Advisory

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by OpenArc Corporate Advisory from 13F filings

Historical chart of OpenArc Corporate Advisory investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by OpenArc Corporate Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by OpenArc Corporate Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 100k 16.45

More positions owned by OpenArc Corporate Advisory

NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Blackrock Etf Trust Ishares A I Inno (BAI)
Tcw Transform Etf Trust Transform System (PWRD)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Msci Eafe (IEFA)
Ab Active Etfs Emerging Mkts Op (EMOP)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Home Depot (HD)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
J P Morgan Exchange Traded F Active Value Etf (JAVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Apple (AAPL)

View all positions for OpenArc Corporate Advisory

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
State Street Corporation
Aisling Capital Management
Geode Capital Management
American Century Companies

View all funds holding Monte Rosa Therapeutics